Skip to content
September 25, 2022

Equity.Guru

Investment information for the new generation

functional mushrooms

Psyched Wellness (PSYC.C) released data from the National Research Council of Canada (NRC) on studies on the neuroprotective properties of their Amanita muscaria mushroom extract, AME-1. The study kicks…
Modern Day Space Race $23.139M Market Capitalization Optimi Health Corp. (OPTI.C) announced today that it has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British Columbia…
Pure Extracts Technologies (PULL.C) exported its first batch of cannabis oil extracts to a German pharmaceutical company under their Health Canada export permit today. PULL bought Canadian grown, EU-GMP…
Week in Review (Week 6) I’ll admit, over the last couple of weeks I have consumed more meat-based dishes than I have plant-based. Does this make me an omnivore,…
Week in Review (Week 5) Change is inevitable. As someone who is terrified of change, that’s a hard pill to swallow. In fact, if you told me that the…
Psyence Group (PSYG.C) started online sales and distribution for their Goodmind line of functional mushroom products today, according to a press release. These mushrooms make broad use of adaptogens,…
In the times of yore before COVID-19 sent us scurrying back to our caves for self-reflection and Overlook Hotel style shenanigans, the brass here at Equity Guru sent me…
Psyched Wellness (PSYC.C) announced that they have completed extraction of AME-1 and have shipped it to their contract research organization in (CRO) partner labs in Asia. The AME-1 was…
Pure Extracts Technologies (PULL.C) subsidiary Pure Mushrooms submitted their class 3 license application to Health Canada’s Natural and Non-Prescription Health Products Directorate for the non-monograph claims of improvements to…
Lobe Sciences (LOBE.C) entered into a production and supply agreement with psychedelics biotech company, HAVN Life Sciences (HAVN.C) today, for their Vitamind line of functional mushrooms, according to a…